Table 3.
Concentration (μmol/L) | Vitamin E | Tocopherols | Probucol | Trolox | |||
---|---|---|---|---|---|---|---|
α | β | γ | δ | ||||
10 | 119 ± 35 | 141 ± 17* | 48 ± 10* | 115 ± 1 | 81 ± 30 | 107 ± 9 | 114 ± 8 |
50 | 126 ± 33 | 149 ± 13* | 18 ± 6* | 25 ± 9* | 0 ± 0* | 98 ± 8 | 105 ± 1 |
100 | 130 ± 25 | 131 ± 15* | 27 ± 8* | 16 ± 9* | 0 ± 0* | 105 ± 10 | 118 ± 13 |
250 | 122 ± 39 | 112 ± 20 | 18 ± 18* | 14 ± 9* | 0 ± 0* | 99 ± 10 | 126 ± 5* |
Day 3 monocyte-derived macrophages were treated with 10 ng/ml of IL-4 and different concentrations of the indicated agents, incubated until day 7, fixed with methanol, and stained with May-Grünwald/Giemsa. The number of adherent macrophages in two low-power fields (×20) was averaged and expressed as a percentage of otherwise untreated macrophages.
*Significantly different from the control value with IL-4 with no other additive (P < 0.05).